JAMA news releases are made available to the public after 3 pm US Central time on the first 4 Tuesdays of each month. The Archives Journals news releases are made available to the public after 3 pm Central time on Mondays. We also provide a list of previous news releases.
THIS WEEK'S CONTENT
JAMA NEWS RELEASES
(Embargoed for Release: 3 p.m. CT, Tuesday, February 17, 2004)
JAMA NEW RELEASES
LONG-TERM USE OF ANTIBIOTICS POSSIBLY LINKED WITH INCREASED RISK OF BREAST CANCER
EFFECTIVENESS OF CHICKENPOX VACCINE DECREASES AFTER ONE YEAR
CARDIOVASCULAR RISK FACTORS MAY ALSO PREDICT DEVELOPMENT OF KIDNEY DISEASE
INFORMATION CONTAINED IN THESE NEWS RELEASES IS PROTECTED BY COPYRIGHT. JOURNAL ATTRIBUTION IS REQUIRED.
TV Note: This week's JAMA video news release is on antibiotics and breast cancer risk. The release will be fed Tuesday, February 17, from 9:00 - 9:30 a.m. ET on Telstar 6, Transponder 11 (C-Band) and from 2:00 - 2:30 p.m. ET on Telstar 6, Transponder 11 (C-Band). For more information, call 312/464-JAMA (5262).
Please Note: Our e-mail has changed to mediarelations{at}jama-archives.org
JOURNALISTS CAN NOW ACCESS EMBARGOED JAMA/ARCHIVES STUDIES ON-LINE
Go to www.jamamedia.org for more information and to apply for access.
Please Note: The FOR THE MEDIA website now has a search feature to enable media to find previous JAMA/Archives news releases on specific medical topics. This search feature link is located on the home page at www.jamamedia.org
EMBARGOED FOR RELEASE: 3 P.M. CT, TUESDAY, February 17, 2004
Media Advisory: To contact corresponding author Susan R. Heckbert, M.D., Ph.D., call Joan DeClaire at 206-287-2653.
To contact editorial corresponding author, Roberta B. Ness, M.D., M.P.H., call Michele Baum at 412-647-3555.
LONG-TERM USE OF ANTIBIOTICS POSSIBLY LINKED WITH INCREASED RISK OF BREAST CANCER
CHICAGOWomen who used increased amounts of antibiotics appear to have a greater risk of breast cancer, according to a new study in the February 18 issue of the Journal of the American Medical Association (JAMA). However, the researchers point out that more studies are needed to determine if the association between breast cancer and antibiotics is causal or if there are other underlying factors to be considered.
"Breast cancer is the most frequently diagnosed nonskin malignancy and the second leading cause of cancer mortality in U.S. women," according to background information from the authors. "It is also the most common cancer in women worldwide, with more than 1 million cases diagnosed each year. Antibiotics are used extensively and overused in many countries, though efforts are underway to curb overuse."
Christine M. Velicer, Ph.D., from the University of Washington, Seattle, and colleagues, examined the association between use of antibiotics and the risk of breast cancer by reviewing medical data from 10,219 women enrolled at Group Health Cooperative (GHC), a large nonprofit health plan in western Washington State. (Dr. Velicer is now on staff at the GHC Center for Health Studies, Seattle.) The study cases included 2,266 women older than 19 years with primary, invasive breast cancer enrolled in the health plan, and 7,953 randomly selected female health plan members who did not have breast cancer in the control group. Data on antibiotic use were obtained from the GHC pharmacy database. The researchers looked at the cumulative number of days of antibiotic use and the total number of antibiotic prescriptions for each study participant.
"We found that increasing cumulative days of antibiotic use and increasing cumulative number of antibiotic prescriptions were associated with increased risk of incident breast cancer, after controlling for age and length of enrollment," the researchers state. For example, compared to women who had used no antibiotics, the researchers found that women who had cumulatively used antibiotics for 1 - 500 days had an associated increased risk of about one-and-a-half times of incident breast cancer. "Increasing cumulative days of antibiotic use was also associated with death due to breast cancer, controlling for age, length of enrollment, and ever use of postmenopausal hormones. All classes of antibiotics were associated with increased risk." The researchers also looked at a subset of study participants with heavy use of macrolide and tetracycline antibiotics and found no difference in risk of incident breast cancer among women using these antibiotics for acne and/or rosacea compared with women using these drugs for respiratory tract infections.
In conclusion, the authors write: "While the implications for clinical practice will not be clear until additional studies are conducted, the results of this study support the continued need for prudent long-term use of antibiotics and the need for further studies of the association between antibiotic use and cancer risk."
(JAMA. 2004;291:827-835. Available post-embargo at jama.com)
Editor's Note: This work was supported in part by grants from the National Cancer Institute and the Gustavus and Louise Pfeiffer Research Foundation.
EDITORIAL: ANTIBIOTICS AND BREAST CANCER
In an accompanying editorial, Roberta B. Ness, M.D., M.P.H., and Jane A. Cauley, Dr.P.H., from the University of Pittsburgh, examine the findings of this study that the use of prescribed antibiotics may be another risk factor for cancer.
"This observation is potentially worrisome in that antibiotic exposure is common and sometimes nonessential. Thus, if real, the risk of breast cancer attributable to the use of antibiotics could be large and partially preventable," the authors write. However, the editorial authors write that the study raises several concerns, including the question of confounding factors in the breast cancer cases cited in the study and the effects of the biological mechanisms of the antibiotics.
"As is often true for reports of new associations, this study provides many (or more) questions than answers. Is the observed link between use of antibiotics and risk of breast cancer confounded by unmeasured factors? Is the effect due to use of antibiotics or to the indications for antibiotics? Does the link suggest caution in the use of antibiotics or suggest that infections at distant sites might promote inflammation localized to the breast? And, whether antibiotics are markers of inflammation or are themselves contributors to carcinogenesis, is use of antibiotics a risk factor for cancers at other sites? Time and further scrutiny will tell. While more research is needed, this study raises the possibility that long-term use of antibiotics may have harmful consequences, especially for patients for whom other therapeutic options are available."
(JAMA. 2004;291:880-881. Available post-embargo at jama.com)
For More Information: Contact the JAMA/Archives Media Relations Department at 312/464-JAMA (5262) or email: mediarelations{at}jama-archives.org (please note new email address).
Go back to the top.
EMBARGOED FOR RELEASE: 3 P.M. CT, TUESDAY, February 17, 2004
Media Advisory: To contact corresponding author Eugene D. Shapiro, M.D., call Karen Peart at 203-432-1326.
EFFECTIVENESS OF CHICKENPOX VACCINE DECREASES AFTER ONE YEAR
CHICAGOThe effectiveness of the chickenpox vaccine decreases significantly in the first year after vaccination, and also appears lower if the vaccine is administered to children younger than 15 months of age, according to a study in the February 18 issue of the Journal of the American Medical Association (JAMA).
According to background information in the article, chickenpox (varicella) vaccine is recommended for routine administration to healthy children at 12 to 18 months of age and to older children who have not yet had chickenpox. Recent reports of outbreaks of chickenpox in groups with substantial rates of immunization have increased concern about the effectiveness of the current recommendations for administration of the vaccine.
Marietta Vazquez, M.D., of the Yale University School of Medicine, New Haven, Conn., and colleagues examined the influence of age at the time of chickenpox vaccination and the time since vaccination on the vaccine's effectiveness. The study, conducted from March 1997 through June 2003, included 339 children 13 months or older who were clinically diagnosed as having chickenpox. For each case subject, two controls were selected, matched by both age and pediatric practice.
The researchers found that although the overall effectiveness of the vaccine was 87 percent, there was a substantial difference in the vaccine's effectiveness in the first year after vaccination (97 percent) and in years 2 to 8 after vaccination (84 percent). "The vaccine's effectiveness in year 1 was substantially lower if the vaccine was administered at younger than 15 months (73 percent) than if it was administered at 15 months or older (99 percent), although the difference in effectiveness overall for children immunized at younger than 15 months was not statistically significantly different than for those immunized at 15 months or older (81 percent vs. 88 percent). Most cases of chickenpox in vaccinees were mild," the authors write.
" … in the United States, deaths from varicella and other complications in immunocompetent persons still occur and will continue to occur until the infection is eliminated. It is important to monitor closely the incidence of varicella and the effectiveness of the vaccine over time to determine if a booster dose is needed to improve its effectiveness," the researchers write.
(JAMA. 2004;291:851-855. Available post-embargo at jama.com)
Editor's Note: For funding and disclosure information of the authors, please see the JAMA article.
For More Information: Contact the JAMA/Archives Media Relations Department at 312/464-JAMA (5262) or email: mediarelations{at}jama-archives.org
Go back to the top.
EMBARGOED FOR RELEASE: 3 P.M. CT, TUESDAY, February 17, 2004
Media Advisory: To contact Caroline S. Fox, M.D., M.P.H., call the NHLBI Communications office at 301-496-4236.
CARDIOVASCULAR DISEASE RISK FACTORS MAY ALSO PREDICT DEVELOPMENT OF KIDNEY DISEASE
CHICAGOEstablished cardiovascular disease risk factors, including high blood pressure, smoking, diabetes, and obesity are associated with the development of kidney disease, according to a study in the February 18 issue of the Journal of the American Medical Association (JAMA).
According to background information provided by the authors, "hypertension and diabetes are the leading causes of end-stage renal disease (ESRD). Among individuals who develop ESRD, the risk of cardiovascular disease is 10 to 20 times higher than the general population, and increased risks are evident even in mild kidney disease." The authors state there are approximately 275,000 patients with ESRD in the U.S. and an estimated 8 million additional U.S. adults have kidney disease.
Caroline S. Fox, M.D., M.P.H., from the National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Mass., and colleagues identified predictors of the development of new-onset kidney disease. The researchers analyzed data from 1,223 men and 1,362 women in the Framingham Offspring Study who had a baseline (initial) examination in 1978 - 1982 and returned for a follow-up examination in 1998 - 2001. None of the participants had kidney disease in the initial examinations. After an average follow-up of 18.5 years, 244 participants (9.4 percent) had developed kidney disease. The researchers defined kidney disease as a decrease in glomerular filtration rate (GFR) [the rate at which the kidneys filter waste] to the fifth percentile or lower, based on national definitions.
The researchers found that established cardiovascular disease risk factors predicted the development of kidney disease. "In addition, a mildly reduced GFR at baseline increased the odds of developing kidney disease. Our data indicate that among unselected participants, diabetes, hypertension, obesity, smoking, low HDL-C level, and a mild reduction in GFR are important risk factors for the development of new-onset kidney disease," the authors write. "Patients with mildly reduced GFR should be monitored for progression to kidney disease."
(JAMA. 2004;291:844-850. Available post-embargo at jama.com)
Editor's Note: The Framingham Heart Study is supported by the National Heart, Lung, and Blood Institute.
For More Information: Contact the JAMA/Archives Media Relations Department at 312/464-JAMA (5262) or email: mediarelations{at}jama-archives.org
Go back to the top.
JAMA REPORTS
ANTIBIOTICS & BREAST CANCER
VIDEO:
Nat sound full patient getting a prescription refilled at pharmacy
AUDIO:
"I need a refill on that."
VIDEO:
B-roll:
Shots of her prescription being filled
Pill bottle, label of bottle
AUDIO:
SIXTY-FOUR YEAR OLD JOAN DRESSLER IS GETTING HER ANTIBIOTIC PRESCRIPTION REFILLED, SOMETHING SHE'S DONE FOR 30 YEARS.
VIDEO:
B-roll:
Shots of Dressler walking
AUDIO:
BUT DRESSLER ALSO HAS A FAMILY HISTORY OF BREAST CANCER AND SHE JUST LEARNED, FROM HER DOCTOR, THERE MIGHT BE A LINK BETWEEN TAKING ANTIBIOTICS AND BREAST CANCER.
VIDEO:
SOT/full
Super @:17
Joan Dressler, Patient
AUDIO:
"When I heard the news about the relationship between antibiotics and breast cancer I was surprised. I'm definitely affected by that news. I immediately saw that I was a long term user of antibiotics and I'm considered at moderate risk in breast cancer."
VIDEO:
B-roll:
Doctor Velicer at computer
Doctor Potter walking
GFX: JAMA cover
AUDIO:
DOCTOR CHRISTINE VELICER OF GROUP HEALTH COOPERATIVE AND DOCTOR JOHN POTTER OF THE FRED HUTCHINSON CANCER RESEARCH CENTER AND COLLEAGUES FROM THE UNIVERSITY OF WASHINGTON, SEATTLE, AUTHORED THE STUDY JUST PUBLISHED IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. THEIR STUDY FOUND A POSSIBLE LINK BETWEEN ANTIBIOTICS AND BREAST CANCER.
VIDEO:
SOT/FULL
Super @:56
Christine Velicer, Ph.D., Group Health Cooperative Researcher
AUDIO:
"The more antibiotics a woman used the higher likelihood she had of developing breast cancer. However, with that said it's very important to note that we can't say from this study that antibiotics actually caused the increased breast cancer risk."
VIDEO:
B-roll:
Doctors talking together going over papers
Shots of antibiotics in pill counter
AUDIO:
VELICER AND POTTER LOOKED OVER THE MEDICAL RECORDS OF MORE THAN 10-THOUSAND WOMEN BETWEEN 1993 AND 2001. THE STUDY FOUND THE LONGER WOMEN WERE ON ANTIBIOTICS, THE HIGHER THEIR RISK OF BREAST CANCER, BUT EVEN WOMEN WHO RARELY TOOK ANTIBIOTICS WERE ALSO FOUND AT A HIGHER RISK.
VIDEO:
B-roll:
Doctors talking together
AUDIO:
BOTH DOCTORS AGREE EVEN WITH THESE RESULTS, ANTIBIOTICS STILL PLAY A USEFUL ROLE IN MEDICINE.
VIDEO:
SOT/FULL
Super @1:32
John Potter, M.D., Ph.D., Fred Hutchinson Cancer Research Center
AUDIO:
"This is not a time to say 'oh, all antibiotics are bad', after all antibiotics are an extremely useful tool for the treatment of infections."
VIDEO:
B-roll:
Dressler at pharmacy
AUDIO:
SO WHAT SHOULD WOMEN DO WHO TAKE ANTIBIOTICS?
VIDEO:
SOT/FULL
Christine Velicer, Ph.D., Group Health Cooperative
AUDIO:
"We would recommend that women continue with their screening mammograms and their breast cancer screening as their health care providers recommend. And also then talking to their doctors when they think they might need antibiotics."
VIDEO:
B-roll:
Dressler walking
AUDIO:
THAT'S EXACTLY WHAT DRESSLER PLANS ON DOING.
VIDEO:
SOT/FULL
Joan Dressler, Patient
AUDIO:
"I'm going to continue my treatment as it is presently and continue my annual mammograms and as I said follow up as best I can with my physicians about the right path I can take."
VIDEO:
B-roll:
Dressler
AUDIO:
THIS IS LAURA MEEHAN REPORTING.